Cointime

Biosortia Microbiomics

company

About

Biosortia works on new drugs from deep access to the chemistry of the microbiome for immuno-oncology and immunological therapeutics.

  • 11 - 50

Highlights

Total Funding Amount
$8M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Seed
Last Funding Money Raised
$8M
Industries
Artificial Intelligence,Biotechnology,Pharmaceutical
Founded date
Jan 1, 2012
Number Of Employee
11 - 50
Operating Status
Active

Biosortia Microbiomics has unique access to the hidden chemistry of the microbiome. The only capability in the world to obtain the long-sought, but previously unobtainable drug-like molecules directly from the microbiome leading to direct access of hidden molecules and filling the key missing data for artificial intelligence (AI).

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$8M
Biosortia Microbiomics has raised a total of $8M in funding over 2 rounds. Their latest funding was raised on Jan 1, 2016 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2016 Seed $8M 1 Keiretsu Forum — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Biosortia Microbiomics is funded by 1 investors. Keiretsu Forum are the most recent investors.
Investor Name Lead Investor Funding Round
Keiretsu Forum Yes Seed
Cointime
เนื้อหา
บริษัท